Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology
Published
2025-12-30
DOI
https://doi.org/10.1186/s12933-025-03018-7
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes

A Mengozzi, FABRIZIA CARLI, Filippo Pratesi, SAMANTHA PEZZICA et al.
Cardiovascular Diabetology
Diabetes Treatment and Management
article

Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes

A Mengozzi, FABRIZIA CARLI, Filippo Pratesi, SAMANTHA PEZZICA, Amalia Gastaldelli, Silvia Sabatini, Anna Solini
article en

Abstract

No abstract available for this paper.
Cardiovascular DiabetologyVol. 25(1)
University of Pisa (IT), The University of Texas at San Antonio Health Science Center (US), University Hospital of Zurich (CH), Istituto di Fisiologia Clinica (IT), Texas Diabetes Institute (US), National Research Council (IT)
Good health and well-being
Openalex Percentile: Top 29%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes — A Mengozzi, FABRIZIA CARLI, et al. · Cardiovascular Diabetology (2025) | TGRS Research Map | TGRS